Concepedia

Eric L. Allen

EL

Statistics

Publications

6

Citations

1.4K

H-Index

6

Active since

2009

Affiliations

Agios Pharmaceuticals (United States)(Current)

California NanoSystems Institute

University of California, Los Angeles

Eric L. Allen is an author at Agios Pharmaceuticals (United States) specializing in cell biology, medicine, and tumor biology.

Top concepts

Publications per year

2009–2019

6

Publications

6

Hexokinase 2 Is Required for Tumor Initiation and Maintenance and Its Systemic Deletion Is Therapeutic in Mouse Models of Cancer

Krushna C. Patra, Qi Wang, Prashanth T. Bhaskar et al. · Cancer Cell · 2013 · 839 citations · Full text

, , +9

PNPASE Regulates RNA Import into Mitochondria

Geng Wang, Hsiao‐Wen Chen, Yavuz Oktay et al. · Cell · 2010 · 362 citations · Full text

, , +6

A chemical biology screen identifies a vulnerability of neuroendocrine cancer cells to SQLE inhibition

Christopher E. Mahoney, David Pirman, Victor Chubukov et al. · Nature Communications · 2019 · 72 citations · Full text

Differential Aspartate Usage Identifies a Subset of Cancer Cells Particularly Dependent on OGDH

Eric L. Allen, Danielle Ulanet, David Pirman et al. · Cell Reports · 2016 · 66 citations · Full text

Expression of sprouty2 inhibits B-cell proliferation and is epigenetically silenced in mouse and human B-cell lymphomas

Matthew J. Frank, David W. Dawson, Steven J. Bensinger et al. · Blood · 2009 · 53 citations · Full text

1–5 of 6